Role of microorganisms in interstitial lung disease

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 5, 2010, Pages 489-495

  Vanfleteren, Lowie E G W ^a   Linssen, Catharina F M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ILD; infection; interstitial lung disease; microorganisms

Indexed keywords

BLEOMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; MACROLIDE; MINOCYCLINE; NITROFURANTOIN; RIFAMPICIN;

ADENOVIRUS; ALLERGIC PNEUMONITIS; ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CONNECTIVE TISSUE DISEASE; COXIELLA BURNETII; CYTOMEGALOVIRUS; DISEASE COURSE; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; HUMAN; HUMAN HERPESVIRUS 8; IDIOPATHIC DISEASE; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION PREVENTION; INFECTION SENSITIVITY; INFLUENZA VIRUS; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LEGIONELLA PNEUMOPHILA; LOEFFLER PNEUMONIA; LUNG ALVEOLUS PROTEINOSIS; LUNG FIBROSIS; LUNG INFECTION; LUNG INJURY; LUNG SARCOIDOSIS; LYMPHOCYTIC INTERSTITIAL PNEUMONIA; MICROORGANISM; NOCARDIA ASTEROIDES; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PROGNOSIS; PSEUDOMONAS AERUGINOSA; REVIEW; SCHIZOPHYLLUM COMMUNE; VARICELLA ZOSTER VIRUS;

BACTERIAL INFECTIONS; HUMANS; IMMUNE SYSTEM; LEGIONNAIRES' DISEASE; LUNG DISEASES, INTERSTITIAL; PNEUMONIA, PNEUMOCYSTIS;

EID: 77955274509     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833b1c54     Document Type: Review

References (58)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165:277-304.
2. Richter AG, McKeown S, Rathinam S, et al. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009; 64:156-161.
3. Agarwal R, Jindal SK. Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur J Intern Med 2008; 19:227-235.
4. Kutok JL, Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 2006; 1:375-404.
5. Marzouk K, Corate L, Saleh S, et al. Epstein-Barr-virus induced interstitial lung disease. Curr Opin Pulm Med 2005; 11:456-460.
6. Lawson WE, Crossno PF, Polosukhin VV, et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am J Physiol Lung Cell Mol Physiol 2008; 294:1119-1126.
7. Vannella KM, Moore BB. Viruses as co-factors for the initiation or exacerbation of lung fibrosis. Fibrogenesis Tissue Repair 2008; 1:2.
8. Chastre J, Raghu G, Soler P, et al. Pulmonary fibrosis following pneumonia due to acute Legionnaires disease. Clinical, ultrastructural, and immunofluorescent study. Chest 1987; 91:57-62.
9. Hürter T, Rumpelt HJ, Ferlinz R. Fibrosing alveolitis responsive to corticosteroids following Legionnaires disease pneumonia. Chest 1992; 101:281-283.
10. Wijnen PA, Drent M, Nelemans PJ, et al. Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands. Drug Saf 2008; 31:1125-1134.
11. Cobben NA, Jacobs JA, van Dieijen-Visser MP, et al. Diagnostic value of BAL fluid cellular profile and enzymes in infectious pulmonary disorders. Eur Respir J 1999; 14:496-502.
12. Hyzy R, Huang S, Myers J, et al. Acute exacerbation of idiopathic pulmonary fibrosis. Chest 2007; 132:1652-1658. (Pubitemid 350156025)
13. Sattler F, Nichols L, Hirano L, et al. Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1997; 156:912-917.
14. Hopewell PC. Pneumocystis carinii pneumonia: diagnosis. J Infect Dis 1988; 157:1115-1119.
15. Parambil JG, Myers JL, Aubry MC, et al. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest 2007; 132:50-57.
16. Helman CA, Keeton GR, Benatar SR. Lymphoid interstitial pneumonia with associated chronic active hepatitis and renal tubular acidosis. Am Rev Respir Dis 1977; 115:161-164.
17. Travis WD, Fox CH, Devaney KO, et al. Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. Hum Pathol 1992; 23:529-541.
18. Joshi VV, Oleske JM, Minnefor AB, et al. Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases. Hum Pathol 1985; 16:241-246.
19. Resnick L, Pitchenik AE, Fisher E, et al. Detection of HTLV-III/LAV-specific IgG and antigen in bronchoalveolar lavage fluid from two patients with lymphocytic interstitial pneumonitis associated with AIDS-related complex. Am J Med 1987; 82:553-556.
20. Barberà JA, Hayashi S, Hegele RG, et al. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992; 145:940-946.
21. Katz BZ, Berkman AB, Shapiro ED. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. J Pediatr 1992; 120:228-232.
22. Perreault C, Cousineau S, DAngelo G, et al. Lymphoid interstitial pneumonia after allogeneic bone marrow transplantation. A possible manifestation of chronic graft-versus-host disease. Cancer 1985; 55:1-9. (Pubitemid 15198191)
23. Poletti V, Costabel U, Casonig Gl, et al. Rare infiltrative lung diseases: a challenge for clinicians. Respiration 2004; 71:431-443. (Pubitemid 39370461)
24. Matsuno O, Ueno T, Takenaka R, et al. Acute eosinophilic pneumonia caused by Candida albicans. Respir Med 2007; 101:1609-1612.
25. Pacheco A, Cuevas M, Carbelo B, et al. Eosinophilic lung disease associated with Candida albicans allergy. Eur Respir J 1998; 12:502-504.
26. Miyazaki E, Sugisaki K, Shigenaga T, et al. A case of acute eosinophilic pneumonia caused by inhalation of Trichosporon terrestre. Am J Respir Crit Care Med 1995; 151:541-543.
27. Ogawa H, Fujimura M, Amaike S, et al. Eosinophilic pneumonia caused by Alternaria alternata. Allergy 1997; 52:1005-1008.
28. Kawayama T, Fujiki R, Rikimaru T, et al. Chronic eosinophilic pneumonia associated with Schizophyllum commune. Respirology 2003; 8:529-531.
29. Ioachimescu OC, Kavuru MS. Pulmonary alveolar proteinosis. Chron Respir Dis 2006; 3:149-159.
30. Bakhos R, Gattuso P, Arcot C, et al. Pulmonary alveolar proteinosis: an unusual association with Mycobacterium avium intracellulare infection and lymphocytic interstitial pneumonia. South Med J 1996; 89:801-802.
31. Couderc LJ, Bernaudin JF, Epardeau B, et al. Pulmonary alveolar proteinosis and disseminated Mycobacteriumavium infection. Respir Med 1996; 90:641-642.
32. Reyes JM, Putong PB. Association of pulmonary alveolar lipoproteinosis with mycobacterial infection. Am J Clin Pathol 1980; 74:478-485.
33. Witty LA, Tapson VF, Piantadosi CA. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis. Medicine (Baltimore) 1994; 73:103-109.
34. Pascual J, Gomez Aguinaga MA, Vidal R, et al. Alveolar proteinosis and nocardiosis: a patient treated by bronchopulmonary lavage. Postgrad Med J 1989; 65:674-677.
35. Ruben FL, Talamo TS. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome. Am J Med 1986; 80:1187-1190.
36. Tran Van Nhieu J, Vojtek AM, Bernaudin JF, et al. Pulmonary alveolar proteinosis associated with Pneumocystis carinii. Ultrastructural identification in bronchoalveolar lavage in AIDS and immunocompromised non-AIDS patients. Chest 1990; 98:801-805.
37. Garrido L, Mata-Essayag S, Hartung de Capriles C, et al. Pulmonary histoplasmosis: unusual histopathologic findings. Pathol Res Pract 2006; 202:373-378.
38. Gumpert BC, Nowacki MR, Amundson DE. Pulmonary alveolar lipoproteinosis. Remission after antibiotic treatment. West J Med 1994; 161:66-68.
39. Drent M, van Nierop MA, Gerritsen FA, et al. A computer program using BALFanalysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996; 153:736-741.
40. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med 2004; 25:447-531.
41. du Bois RM, Goh N, McGrath D, et al. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med 2003; 253:4-17.
42. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357:2153-2165.
43. Schilstra A, Rottoli P, Jacobs JA, et al. Case studies to explore the pitfalls in the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23:135-140.
44. Newman LS. Aetiologies of sarcoidosis. Eur Respir Mon 2005; 32:23-48.
45. Gupta D, Agarwal R, Aggarwal AN, et al. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007; 30:508-516.
46. Carlisle J, Evans W, Hajizadeh R, et al. Multiple Mycobacterium antigens induce interferon-c production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol 2007; 150:460-468.
47. Saltini C, Pallante M, Puxeddu E, et al. M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25:100-116.
48. Grutters JC, Drent M, van den Bosch JMM. Sarcoidosis. Eur Respir Mon 2009; 46:126-154.
49. Ichiyasu H, Suga M, Matsukawa A, et al. Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits. J Leukoc Biol 1999; 65:482-491.
50. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002; 40:198-204.
51. Nilsson K, Pahlson C, Lukinius A, et al. Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis. J Infect Dis 2002; 185:1128-1138.
52. Puolakkainen M, Campbell LA, Kuo CC, et al. Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infect 1996; 33:199-205.
53. Hua B, Li QD, Wang FM, et al. Borrelia burgdorferi infection may be the cause of sarcoidosis. Chin Med J (Engl) 1992; 105:560-563.
54. Redondo P, Espana A, Sola J, et al. Sarcoid-like granulomas secondary to herpes simplex virus infection. Dermatology 1992; 185:137-139.
55. Hanngren A, Biberfeldt G, Carlens E, et al. Is sarcoidosis due to an infectious interaction between virus and mycobacterium? In: Iwai K, Hosoda Y, editors. Proceedings of 6th International Conference on Sarcoidosis. Tokyo: Tokyo Press; 1974. pp. 8-11.
56. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374:1543-1556.
57. Cottin V, Bonniaud P. Drug-induced infiltrative lung disease. Eur Respir Mon 2009; 46:287-318.
58. Spagnolo P, Richeldi L, Raghu G. The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases. Eur Respir Mon 2009; 46:36-46.